http://www.bing.com/newsSearch Results for pharmaceutical at Bing.comNews21500010These XML results may not be used, reproduced or transmitted in any manner or for any purpose other than rendering Bing results within an RSS aggregator for your personal, non-commercial use. Any other use requires written permission from Microsoft Corporation. By using these results in any manner whatsoever, you agree to be bound by the foregoing restrictions.http://www.bing.com/s/a/rsslogo.gifhttp://www.bing.com/newshttp://www.rssboard.org/rss-specificationhttp://www.marketwatch.com/story/ohr-pharmaceutical-issues-letter-to-shareholders-2012-07-31http://www.marketwatch.com/story/ohr-pharmaceutical-issues-letter-to-shareholders-2012-07-31NEW YORK, NY, Jul 31, 2012 (MARKETWIRE via COMTEX) -- Ohr Pharmaceutical Inc. (OBB:OHRP) , a pharmaceutical company dedicated to developing novel treatments for large unmet medical needs, issued the following letter to shareholders today: I ...2012-08-01T00:53:01ZMarketwatchhttp://india.nydailynews.com/newsarticle/50118669c3d4ca9277000005/pharmaceutical-companies-putting-health-of-world-s-poor-at-riskhttp://india.nydailynews.com/newsarticle/50118669c3d4ca9277000005/pharmaceutical-companies-putting-health-of-world-s-poor-at-riskIndia is often called the pharmacy of the developing world, which is no great surprise as more than 50% of its $10bn annual generic medicine production is exported. But the domestic drug industry behind India's role as global pharmacist stands ...2012-07-26T18:25:14Zindia.nydailynews.comhttp://www.bloomberg.com/news/2012-07-26/par-pharmaceutical-sued-by-investor-over-1-9-billion-buyout.htmlhttp://www.bloomberg.com/news/2012-07-26/par-pharmaceutical-sued-by-investor-over-1-9-billion-buyout.htmlPar Pharmaceutical Cos. (PAR), the generic-drug maker being bought by TPG Capital for $1.9 billion, was sued by a shareholder who contends investors will be shortchanged in the deal. Directors of Woodcliff Lake, New Jersey-based Par are duty ...2012-07-26T13:38:54ZBloomberghttp://www.msnbc.msn.com/id/48411307http://www.msnbc.msn.com/id/48411307MarketResearch.com has announced the addition of the new report "Active Pharmaceutical Ingredients (API) Market in Europe to 2017 -- Pricing and Reimbursement Initiatives Supporting Generic Drug Growth, with CMOs Expected to Account for Majority of the ...2012-07-31T08:03:41ZNBCNews.comhttp://seekingalpha.com/article/767821-3-analyst-backed-pharmaceutical-stocks-with-great-projectionshttp://seekingalpha.com/article/767821-3-analyst-backed-pharmaceutical-stocks-with-great-projectionsFor investors specifically interested in keeping tabs on the pharmaceutical industry, checking in with the latest news from analysts can be a helpful tool in finding new opportunities. Today, we have a quick list of pharmaceutical stocks that have been ...2012-08-01T04:06:17ZSeekingalpha.comhttp://www.fool.com/investing/general/2012/07/31/will-teva-pharmaceutical-industries-beat-these-an.aspxhttp://www.fool.com/investing/general/2012/07/31/will-teva-pharmaceutical-industries-beat-these-an.aspxComparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Teva Pharmaceutical Industries' revenue will expand 20.6% and EPS will increase 16.4%. The average estimate for revenue is $5.08 billion. On the bottom ...2012-07-31T13:40:08ZMotley Foolhttp://finance.yahoo.com/news/raptor-pharmaceutical-announces-issuance-key-103000006.htmlhttp://finance.yahoo.com/news/raptor-pharmaceutical-announces-issuance-key-103000006.htmlNOVATO, Calif., July 30, 2012 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (RPTP), today announced that the European Patent Office has issued a key patent covering enteric-coated oral formulations of cysteamine ...2012-07-30T10:42:22ZYahoo Financehttp://www.prlog.org/11937050-pharmaceutical-leaders-2012-top-performers-analysis-report-available-from-marketresearchreportsin.htmlhttp://www.prlog.org/11937050-pharmaceutical-leaders-2012-top-performers-analysis-report-available-from-marketresearchreportsin.htmlLeading business intelligence provider Publisher is pleased to announce the publication of its 2012 Pharmaceutical Benchmark Report, the first in a series of annual reports completed by its newly established Boston, Massachusetts, Industry Dynamics Team.2012-07-30T09:52:15ZPRLog (free press release)http://www.transworldnews.com/1117925/c1/teva-pharmaceutical-industries-limited-teva-company-profile-and-swot-analysis-new-company-profile-reporthttp://www.transworldnews.com/1117925/c1/teva-pharmaceutical-industries-limited-teva-company-profile-and-swot-analysis-new-company-profile-reportTeva Pharmaceutical Industries Limited (Teva) develops, produces and markets a range of generic and branded pharmaceuticals, biogenerics and active pharmaceutical ingredients (APIs). The company's products focus on various therapeutic areas including ...2012-07-30T14:38:35ZTransworld Newshttp://markets.ft.com/Research/Markets/Tearsheets/Business-profile?s=950:HKGhttp://markets.ft.com/Research/Markets/Tearsheets/Business-profile?s=950:HKGLee's Pharmaceutical Holdings Limited is an investment holding company. The Company segments proprietary products, which is engaged in manufacturing and sale of self-developed pharmaceutical products, and licensed products, which is engaged in trading of ...2012-07-31T03:31:41ZFinancial Times